Homocysteine and Parkinson's disease: A dangerous liaison?
- 1 June 2007
- journal article
- conference paper
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 257 (1-2) , 31-37
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Effects of folic acid supplementation on psychomotor performance and hemorheology in healthy elderly subjectsArchives of Gerontology and Geriatrics, 2006
- Effect of acute hyperhomocysteinemia on methylation potential of erythrocytes and on DNA methylation of lymphocytes in healthy male volunteersAmerican Journal of Physiology-Renal Physiology, 2005
- Homocysteine Enhances Endothelial Apoptosis via Upregulation of Fas-Mediated PathwaysHypertension, 2004
- Presenilin 1 gene silencing by S‐adenosylmethionine: a treatment for Alzheimer disease?FEBS Letters, 2003
- Moderate hyperhomocysteinaemia and immune activation in Parkinson's diseaseJournal of Neural Transmission, 2002
- Treatment of hyperhomocysteinemia with folic acid reduces oxidative stress in renal transplant recipientsTransplantation, 2002
- Elevated Plasma Levels of Homocysteine inParkinson’s DiseaseEuropean Neurology, 1998
- The neurotransmitter candidature of sulphur-containing excitatory amino acids in the mammalian central nervous systemPharmacology & Therapeutics, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Oxidative stress as a mediator of apoptosisImmunology Today, 1994